Sartorius Stedim Biotech S.A
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more
Sartorius Stedim Biotech S.A - Asset Resilience Ratio
Sartorius Stedim Biotech S.A (SDMHF) has an Asset Resilience Ratio of 0.10% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2025)
This chart shows how Sartorius Stedim Biotech S.A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Sartorius Stedim Biotech S.A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $8.10 Million | 0.1% |
| Total Liquid Assets | $8.10 Million | 0.10% |
Asset Resilience Insights
- Limited Liquidity: Sartorius Stedim Biotech S.A maintains only 0.10% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sartorius Stedim Biotech S.A Industry Peers by Asset Resilience Ratio
Compare Sartorius Stedim Biotech S.A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
OJsys Inc
PINK:OJSY |
Medical Instruments & Supplies | 0.00% |
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931 |
Medical Instruments & Supplies | 0.06% |
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 5.12% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 35.75% |
|
Allmed Medical Products Co Ltd Class A
SHE:002950 |
Medical Instruments & Supplies | 3.78% |
|
Inix Technologies Holdings Bhd
KLSE:0094 |
Medical Instruments & Supplies | 0.06% |
|
Focus Point Holdings Bhd
KLSE:0157 |
Medical Instruments & Supplies | 2.30% |
|
Careplus Group Bhd
KLSE:0163 |
Medical Instruments & Supplies | 4.91% |
Annual Asset Resilience Ratio for Sartorius Stedim Biotech S.A (2008–2025)
The table below shows the annual Asset Resilience Ratio data for Sartorius Stedim Biotech S.A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.10% | $8.10 Million | $8.01 Billion | -0.02pp |
| 2024-12-31 | 0.12% | $9.90 Million | $8.26 Billion | 0.00pp |
| 2023-12-31 | 0.12% | $9.50 Million | $7.74 Billion | -0.39pp |
| 2022-12-31 | 0.51% | $25.90 Million | $5.07 Billion | +0.16pp |
| 2021-12-31 | 0.35% | $13.72 Million | $3.95 Billion | +0.03pp |
| 2020-12-31 | 0.32% | $9.84 Million | $3.07 Billion | -0.68pp |
| 2019-12-31 | 1.01% | $18.30 Million | $1.82 Billion | -0.22pp |
| 2018-12-31 | 1.22% | $19.21 Million | $1.57 Billion | +0.31pp |
| 2017-12-31 | 0.91% | $12.84 Million | $1.40 Billion | +0.22pp |
| 2016-12-31 | 0.69% | $8.27 Million | $1.20 Billion | -0.09pp |
| 2015-12-31 | 0.78% | $8.35 Million | $1.07 Billion | +0.03pp |
| 2014-12-31 | 0.75% | $6.79 Million | $906.76 Million | -0.02pp |
| 2013-12-31 | 0.77% | $6.70 Million | $871.23 Million | -0.13pp |
| 2012-12-31 | 0.89% | $7.10 Million | $793.87 Million | +1.15pp |
| 2008-12-31 | -0.26% | $-1.69 Million | $652.34 Million | -- |